Artificial miRNAs Targeting Mutant Huntingtin Show Preferential Silencing In Vitro and In Vivo
Huntington's disease (HD) is a dominantly inherited neurodegenerative disease caused by CAG repeat expansion in exon 1 of huntingtin (HTT). Studies in mouse models of HD with a regulated mutant transgene show that continuous mutant allele expression is required for behavioral and pathological s...
Saved in:
Main Authors: | Alex Mas Monteys (Author), Matthew J Wilson (Author), Ryan L Boudreau (Author), Ryan M Spengler (Author), Beverly L Davidson (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A CAG repeat-targeting artificial miRNA lowers the mutant huntingtin level in the YAC128 model of Huntington's disease
by: Anna Kotowska-Zimmer, et al.
Published: (2022) -
Safe and Efficient Silencing with a Pol II, but Not a Pol lII, Promoter Expressing an Artificial miRNA Targeting Human Huntingtin
by: Edith L. Pfister, et al.
Published: (2017) -
Taking a Break From Huntingtin
by: Beverly L Davidson
Published: (2012) -
Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease
by: Jana Miniarikova, et al.
Published: (2016) -
The flavonoid luteolin reduces mutant huntingtin aggregation and cytotoxicity in huntingtin-mutated neuroblastoma cells
by: Azza Ramadan, et al.
Published: (2023)